3-8630810-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001256748.3(SSUH2):c.520G>A(p.Val174Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000335 in 1,462,278 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V174F) has been classified as Uncertain significance.
Frequency
Consequence
NM_001256748.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SSUH2 | NM_001256748.3 | c.520G>A | p.Val174Ile | missense_variant | 6/12 | ENST00000544814.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SSUH2 | ENST00000544814.7 | c.520G>A | p.Val174Ile | missense_variant | 6/12 | 2 | NM_001256748.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000250 AC: 4AN: 159768Hom.: 0 AF XY: 0.0000115 AC XY: 1AN XY: 87108
GnomAD4 exome AF: 0.0000298 AC: 39AN: 1310096Hom.: 0 Cov.: 30 AF XY: 0.0000294 AC XY: 19AN XY: 646444
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 03, 2022 | The c.454G>A (p.V152I) alteration is located in exon 6 (coding exon 3) of the SSUH2 gene. This alteration results from a G to A substitution at nucleotide position 454, causing the valine (V) at amino acid position 152 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at